Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 660 of 5804
-
New combo aims to wipe out rare bladder cancer before surgery
Disease control Recruiting nowThis is a single arm, Phase II trial involving the use of atezolizumab plus platinum and etoposide for patients with locally advanced urothelial cancer. The primary goal of this trial is to assess the pathologic complete response rate at cystectomy in patients after being treated…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Contact lenses that could slow nearsightedness in kids
Disease control OngoingThe purpose of this post-approval study is to confirm the effectiveness of the MiSight 1 Day lens in clinical practices within the US and to assess the stability of the myopia reduction over one-year post-treatment.
Phase: NA • Sponsor: CooperVision, Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New hybrid heart procedure aims to tame stubborn AFib in heart failure patients
Disease control Recruiting nowA randomised controlled trial to assess the efficacy of staged hybrid ablation when compared with standard catheter ablation in patients with non-paroxysmal atrial fibrillation (AF) and Heart Failure
Phase: NA • Sponsor: St. George's Hospital, London • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a simple shot replace IV drips for blood cancer patients?
Disease control OngoingThis is a randomized, multicenter, Phase 3, open-label study evaluating subcutaneous (SC) vs intravenous (IV) administration of isatuximab in combination with pomalidomide and dexamethasone (Pd) in RRMM patients (study participants) who have received at least 1 prior line of ther…
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could a simple ear device ease chemo nausea without extra drugs?
Symptom relief Recruiting nowDespite pharmaceutical innovations, chemotherapy induced nausea is frequent and largely participating to alter our patients quality of life. Non invasive vagal stimulation is approved in other health issues, for example in headache or gastroparesis, with a reported benefit on na…
Phase: NA • Sponsor: University Hospital, Tours • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New lotion could ease rare skin disorder
Disease control OngoingThis study has been designed to determine the safety, tolerability and efficacy of QRX003 lotion 2%, 4% QAM or 4% BID in subjects with Netherton Syndrome (NS) in comparison to vehicle
Phase: PHASE2, PHASE3 • Sponsor: Quoin Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New drug hopes to stop relapses in kids with rare nerve disease
Disease control OngoingThe primary purpose of this study is to evaluate the safety and efficacy of ravulizumab in pediatric participants with Neuromyelitis Optica Spectrum Disorder (NMOSD).
Phase: PHASE2, PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could two kidney drugs together be better than one?
Disease control CompletedFinerenone works by blocking a group of proteins, called mineralocorticoid receptor. An increased stimulation of mineralocorticoid receptor is known to trigger injury and inflammation in the kidney and is therefore thought to play a role in CKD. Empagliflozin lowers blood sugar …
Phase: PHASE2 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Bladder cancer breakthrough? drug combo aims to stop tumors returning
Disease control Recruiting nowThis is a phase II randomized controlled clinical trial comparing standard induction BCG versus bicalutamide and standard induction BCG among patients with non-muscle invasive bladder cancer.
Phase: PHASE2 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New mRNA vaccines for kids under 6 show promise in phase 3 trial
⭐️ VACCINE ⭐️ CompletedThis study will evaluate the safety and immunogenicity of the mRNA-1273.214 vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concerns (VOCs) in participants aged 6 months to \<6 years, when administered as a primary series in SARS-CoV-2 vaccine-…
Phase: PHASE3 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:00 UTC
-
New ointment shows promise for rare skin condition
Disease control CompletedThis is a randomized, double-blind and vehicle-controlled Phase III study to evaluate the safety and efficacy of topical TMB-001 0.05% ointment for the treatment of congenital ichthyosis (CI) in subjects with either the RXLI or ARCI subtypes. In addition, a subset of preselected…
Phase: PHASE3 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for Hard-to-Treat lymphoma: targeted drug shows promise
Disease control Recruiting nowThe purpose of this research study is to see if loncastuximab tesirine has any benefits at dose levels researchers found acceptable in earlier studies in patients with related forms of immune cell cancers. The researchers want to find out the effects (good and bad) that loncastux…
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Experimental Alzheimer's vaccine aims to clear brain plaques
Disease control Recruiting nowThe purpose of this study is to assess the safety, tolerability, immunogenicity and pharmacodynamic effects of ACI-24.060 in subjects with prodromal Alzheimer's disease and in non-demented adults with Down syndrome.
Phase: PHASE1, PHASE2 • Sponsor: AC Immune SA • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Smart blood tests may personalize lung cancer care after targeted therapy
Disease control OngoingThis is an open-label, multi-center, randomized, phase III study. It is aimed to firstly evaluate the effectiveness and safety of almonertinib induction therapy in EGFR-mutated patients with unresectable stage III non-small cell lung cancer, and to evaluate the effectiveness and …
Phase: PHASE3 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a once-weekly shot protect joints in hemophilia a? new study aims to find out.
Disease control OngoingStudy MO42623 is a Phase IV, multicenter, open-label, three cohort study designed to evaluate the impact of emicizumab prophylaxis on overall health, physical activity, and joint outcomes in participants aged ≥13 and \<70 years with severe hemophilia A without factor VIII (FVIII)…
Phase: PHASE4 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New heart valve could save lives without Open-Heart surgery
Disease control Recruiting nowThe objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4/X4S Transcatheter Heart Valve (THV) in subjects with symptomatic, severe, calcific aortic stenosis (AS).
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Treating Mom's depression may help Baby's brain
Disease control OngoingThe primary objective of this study is to determine if online group cognitive behavioral therapy (CBT) for maternal postpartum depression (PPD) added to treatment as usual (TAU) leads to greater improvements in infant emotion regulation (ER) than maternal receipt of TAU alone imm…
Phase: NA • Sponsor: McMaster University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New shot could free teens with PKU from strict diet
Disease control OngoingThis is a Phase 3 open-label randomized controlled study enrolling approximately 54 adolescents with PKU. The study is designed to assess the safety and efficacy of pegvaliase injections.
Phase: PHASE3 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could a vaccine help fight throat cancer? new trial tests promising combo
Disease control OngoingThis phase I/II trial studies how well PDS0101 alone or in combination with pembrolizumab works to shrink tumor in patients with human papillomavirus-associated oropharynx cancer that has spread to nearby tissue or lymph nodes (locally advanced). PDS0101 is a vaccine made from sp…
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New blood test could spot hidden cancer cells that spread
Diagnosis Recruiting nowIn solid cancers, some more aggressive tumor cells actively detach from the primary lesion and then travel through the circulating compartment to reach distant organs and form micro-metastases. These circulating tumor cells (CTCs) that have become disseminated tumor cells (DTCs) …
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC